Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...

Luxembourg's Ministry of Health and Social Security has reported that a safety notice regarding certain models... }} ...

Baxter will share an update on Hurricane Helene’s impact, while Medtronic will likely discuss a new pulsed field ablation ...

Thus, the pump may stop insulin delivery ... 2023 to September 2024, Medtronic reported receiving 170 reports of hyperglycemia above 400 mg/dL, and 11 reports of diabetic ketoacidosis related ...

Medtronic, which has operational headquarters in Fridley, has recalled 24,595 battery-operated pumps ... of diabetes that occurs when the body doesn’t have enough insulin. Class I recalls ...

Insulin pump therapy ... novel diagnostic and therapeutic options for diabetes therapy, including Roche Diagnostics, Sanofi, Abbott, and Medtronic. G.A.F. is President and CEO of Kinexum, which ...

"This may result in the pump stopping insulin delivery significantly sooner than usually expected." Medtronic said this ... consequences like hyperglycemia, diabetic ketoacidosis, or death.

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

Defensive industries, like healthcare, are more attractive to income investors. That's because companies in this sector are ...

This malfunction could halt insulin delivery prematurely, leading to serious conditions such as hyperglycemia or diabetic ...

Medtronic MiniMed Medtronic recalled its MiniMed 600 and 700 series insulin pumps Oct. 24 due to reduced ... potentially leading to hyperglycemia or diabetic ketoacidosis. The FDA advised users ...